Sai Life Sciences Sustainability Report 2023

12 Discovery services spanning the entire journey from Target ID and validation to IND Sai Life Sciences delivers integrated discovery services seamlessly spanning synthetic and medicinal chemistry, biology, DMPK and toxicology to a global client base across diverse therapeutic areas. The organization has completed over 200 discovery programs across oncology, CNS, inflammation, antivirals, rare diseases, and more. Today we serve many innovator companies spanning biotechs, small to mid and big pharma across US, UK, EU and Japan. The discovery vertical of Sai Life Sciences has over 1000 employees across its sites in Boston and Hyderabad, and has a comprehensive range of offerings. Preclinical toxicology Drug substance/Product Med Chem Design Synthesis ADME PK Pre Formulation Biology Two global sites delivering integrated value Transfer to India reduces costs and cycle-time Our discovery biology team co-located in a single integrated campus with our teams in medicinal chemistry, process development, process engineering and scale-up enables us to accelerate our clients’ discovery programs through rapid turnaround times and shorter decision-making cycles. Exploratory focus allows clients to externalize complex biology projects that necessitate more fluid experimental design with realtime decision making. Boston Fully integrated R&D campus housing Discovery, Development, Process Engineering, pilot plant and early phase delivery. Hyderabad

RkJQdWJsaXNoZXIy MTIwMDc4NQ==